Amazon said Tuesday that it will stop testing jobseekers for marijuana.
The company, the second-largest private employer in the U.S. behind Walmart, is making the change as states legalize cannabis or introduce laws banning employers from testing for it.
In March, a New York man sued Amazon, saying the company rescinded his job offer at an Amazon warehouse because he tested positive for marijuana, even though the city banned employers from testing job applicants for cannabis in 2020.
Amazon said in a blog post that it will still test workers for other drugs and conduct “impairment checks” on the job. And the company said some roles may still require a cannabis test in line with Department of Transportation regulations.
Seattle-based Amazon also said Tuesday that it will support the federal legalization of marijuana by pushing lawmakers to pass the Marijuana Opportunity Reinvestment and Expungement Act of 2021.
At some 940-pages, the legislation is a sprawling collection of tax breaks, spending cuts and other Republican priorities, including new money for national defense and deportations.
Chris Versace, CIO at Tematica Research, joins to discuss earnings season trends, Flash PMI signals, Walmart’s strategy updates, and Nike’s evolving outlook.
Andrew Nusca, Editorial Director at Fortune, dives into WhatsApp’s first-ever ads rollout —and how Meta’s ad push intensifies its showdown with OpenAI.
Ben Geman, Energy Reporter at Axios, joins to discuss the latest Middle East tensions, Brent crude price swings, and why gas prices aren’t falling with oil.
Al Root, Associate Editor at Barron's, joins to discuss Tesla’s robotaxis going live in Texas—what it means for autonomy, safety, and the EV race ahead.
Dena Jalbert, M&A expert and CEO of Align Business Advisory Services, on the state of U.S. M&A: deals worth $1–$10 billion (including debt) are surging.
